Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders

Epstein‐Barr virus (EBV) is a well‐established tumor virus that has been implicated in a wide range of immunodeficiency‐associated lymphoproliferative disorders (LPDs). Although rituximab, a CD20 mAb, has proven effective against EBV‐associated LPDs, prolonged use of this drug could lead to resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Takahiro, Sato, Yoshitaka, Masud, H. M. Abdullah Al, Takayama, Masahiro, Matsuda, Hiroki, Hara, Yuya, Yanagi, Yusuke, Yoshida, Masahiro, Goshima, Fumi, Murata, Takayuki, Kimura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942432/
https://www.ncbi.nlm.nih.gov/pubmed/31743514
http://dx.doi.org/10.1111/cas.14241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942432/
https://www.ncbi.nlm.nih.gov/pubmed/31743514
http://dx.doi.org/10.1111/cas.14241

Ejemplares similares